A second look at the status quo for secondary acute myeloid leukemia after hypomethylating agents. Peters DT, Zeidner JF. Cancer 2025;131:e35838.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Peters DT, Zeidner JF. A second look at the status quo for secondary acute myeloid leukemia after hypomethylating agents. Cancer 2025;131:e35838.
PMID: 40193181